Clinical Trial Update: Role of Triggering Receptor Expressed on Myeloid Cells (TREM-1) as a Novel Biomarker in Human Epidermal Growth Factor Receptor -2 (HER-2) Negative Breast Cancer: a Molecular and Clinical Study

View source ↗

Summary

This clinical trial update evaluates triggering receptor expressed on myeloid cells-1 (TREM-1) as a novel biomarker in HER2-negative breast cancer, including ea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Rahma Esam Salama Esawi | Conditions: Breast Cancer Stage I, Breast Cancer Stage II | Status: NOT_YET_RECRUITING